Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 24, 2001

View Archived Issues

Study In Twins Points To Role Of Genetic Heart Disease Factors

London Exchange Might Ease Listing Rules For Young Firms

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

European Bioethics Committee Starts Work, Elects President

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

IsoTis Completes Implants Of Autologous Living Bone Tissue

European Pharma Industry Calls For New Evaluation Structure

Other News To Note

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Cerep, Four European Companies Align To Create Compound Library

Genset Subscribes To Celera Products For Genomics Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...